Why MannKind Corporation (MNKD) is One of the Best Stocks Under $5 With Huge Upside Potential

MannKind Corporation (NASDAQ:MNKD) is one of the best stocks under $5 with huge upside potential. Mizuho cut the price target on MannKind Corporation (NASDAQ:MNKD) to $8 from $10 on April 13 and reaffirmed an Outperform rating on the shares. The firm adjusted price targets and estimates for a number of stocks under its coverage in the medical devices and diagnostics group ahead of its fiscal Q1 earnings.

Is MannKind Corporation (MNKD) the Best Cancer Stock to Invest in for Long-Term Gain?

MannKind Corporation (NASDAQ:MNKD) also received a rating update from Truist on April 8. The firm cut the price target on the stock to $6 from $7, reiterating a Buy rating on the shares. The rating update came as part of a broader research note previewing fiscal Q1 earnings in Biotech, with the firm telling investors in the research note that reactivity to regulatory and policy shifts across the sector is continuing to ease. Truist also stated that it is seeing a recent pickup in deal activity, which holds the potential to build momentum through the remainder of the year into midterms.

The firm sees a robust catalyst path for MannKind Corporation (NASDAQ:MNKD), which could spark momentum for shares, with peds Afrezza label expansion PDUFA set for May 29, 2026, Furoscix ReadyFlow autoinjector PDUFA on July 26, and developmental updates for MNKD-201 in IPF – Part 1 of the phase 1b INFLO study expected to be completed this month.

MannKind Corporation (NASDAQ:MNKD) is a biopharmaceutical company that develops and commercializes innovative therapeutic devices and products that address serious unmet medical needs for endocrine and orphan lung diseases. The company’s pipeline and products include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.

While we acknowledge the risk and potential of MNKD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MNKD and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.